About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Fischer Medical Ventures Ltd.
Change Company
BSE Code
524743
ISIN Demat
INE771F01041
Book Value
4.77
NSE Code
FISCHER
Dividend Yield %
0.01
Market Cap
26589.13
P/E
0.00
EPS
-0.01
Face Value
1
1 Week
1 Month
3 Months
6 Months
1 Year
13-Nov-2025
Fischer Medical Ventures’ arm wins order worth Rs...
13-Nov-2025
Fischer Medical Ventures informs about press rel...
11-Nov-2025
Fischer Medical Ventures informs about press rele...
07-Nov-2025
Fischer Medical Ventures informs about audio reco...
03-Nov-2025
Fischer Medical Ventures informs about press rel...
29-Oct-2025
Fischer Medical Ventures informs about press rele...
23-Oct-2025
Fischer Medical Ventures informs about press rel...
23-Oct-2025
Fischer Medical Ventures informs about board meet...
16-Oct-2025
Fischer Medical Ventures informs about updates
16-Sep-2025
Dividend Clarification
10-Sep-2025
ISIN Change
01-Sep-2025
Fischer Medical Ventures informs about results o...
30-Jul-2025
Fischer Medical Ventures informs about postal bal...
11-Jul-2025
Fischer Medical Ventures partners with City of Je...
11-Jul-2025
Fischer Medical Ventures zooms on partnering with...
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.